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Beta burst dynamics in Parkinson’s disease OFF
and ON dopaminergic medication
Gerd Tinkhauser,1,2,3 Alek Pogosyan,1,2 Huiling Tan,1,2 Damian M. Herz,1,2 Andrea A. Ku¨hn4
and Peter Brown1,2
Exaggerated basal ganglia beta activity (13–35Hz) is commonly found in patients with Parkinson’s disease and can be suppressed
by dopaminergic medication, with the degree of suppression being correlated with the improvement in motor symptoms.
Importantly, beta activity is not continuously elevated, but ﬂuctuates to give beta bursts. The percentage number of longer beta
bursts in a given interval is positively correlated with clinical impairment in Parkinson’s disease patients. Here we determine
whether the characteristics of beta bursts are dependent on dopaminergic state. Local ﬁeld potentials were recorded from the
subthalamic nucleus of eight Parkinson’s disease patients during temporary lead externalization during surgery for deep brain
stimulation. The recordings took place with the patient quietly seated following overnight withdrawal of levodopa and after
administration of levodopa. Beta bursts were deﬁned by applying a common amplitude threshold and burst characteristics were
compared between the two drug conditions. The amplitude of beta bursts, indicative of the degree of local neural synchronization,
progressively increased with burst duration. Treatment with levodopa limited this evolution leading to a relative increase of
shorter, lower amplitude bursts. Synchronization, however, was not limited to local neural populations during bursts, but also,
when such bursts were cotemporaneous across the hemispheres, was evidenced by bilateral phase synchronization. The probability
of beta bursts and the proportion of cotemporaneous bursts were reduced by levodopa. The percentage number of longer beta
bursts in a given interval was positively related to motor impairment, while the opposite was true for the percentage number of
short duration beta bursts. Importantly, the decrease in burst duration was also correlated with the motor improvement. In con-
clusion, we demonstrate that long duration beta bursts are associated with an increase in local and interhemispheric synchronization.
This may compromise information coding capacity and thereby motor processing. Dopaminergic activity limits this uncontrolled
beta synchronization by terminating long duration beta bursts, with positive consequences on network state and motor symptoms.
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Introduction
Basal ganglia beta activity (13–35Hz) is well known to be
exaggerated in patients with Parkinson’s disease, and the
amplitude of such activity has been linked to motor impair-
ment (Brown, 2003) and dopaminergic tone (Jenkinson and
Brown, 2011). In particular, the reduction in beta power in
the local ﬁeld potential (LFP) recorded in the subthalamic
nucleus (STN) after administration of levodopa and during
continuous high frequency deep brain stimulation (DBS) is
positively correlated with improvement of motor impair-
ment (Ku¨hn et al., 2006, 2008, 2009; Chen et al., 2010;
Lo´pez-Azca´rate et al., 2010; Eusebio et al., 2011; O¨zkurt
et al., 2011; Oswal et al., 2016; Trager et al., 2016). As
such, beta activity in the STN has been used as a feedback
signal in amplitude-responsive closed-loop DBS, where
stimulation is delivered when beta amplitude rises above
a certain threshold (Little et al., 2013a) or in proportion
to beta amplitude (Rosa et al., 2015, 2017). Initial, albeit
acute, studies have suggested that this adaptive approach
can be at least as effective as conventional, continuous
DBS, while using less battery power and incurring fewer
stimulation-induced side effects, such as speech impairment
and dyskinesias (Little et al., 2013a, 2016a, b; Rosa et al.,
2015, 2017; Pina-Fuentes et al., 2017).
However, one unresolved aspect of the pathological ex-
aggeration of beta activity in Parkinson’s disease that im-
pacts on the delivery of adaptive DBS is whether beta
activity is tonically or phasically elevated. Evidence is be-
ginning to accrue that physiological beta activity consists of
short-lived phasic bursts in basal ganglia-cortical motor cir-
cuits (Murthy and Fetz, 1992, 1996; Feingold et al., 2015)
and studies in Parkinson’s disease patients undergoing DBS
suggest that pathological beta activity may tend to consist
of longer duration, phasic bursts (Tinkhauser et al., 2017).
Adaptive DBS has therefore been suggested to selectively
trim longer beta bursts leading to a redistribution of beta
bursts towards shorter, more physiological, durations
(Tinkhauser et al., 2017). Here we test the hypotheses
that pathological beta activity consists of prolonged
bursts in Parkinson’s disease, that these bursts are asso-
ciated with excessive synchronization within and between
basal ganglia circuits and that such bursts are abbreviated
and made less frequent by treatment with the dopaminergic
prodrug, levodopa, thereby contributing to improved
motor function.
Materials and methods
Subjects and surgery
We investigated beta bursts before and after administration of
levodopa in eight patients (16 hemispheres) with advanced
Parkinson’s disease undergoing DBS surgery targeting the
STN (Table 1). All subjects have been previously reported
(Ku¨hn et al., 2006). They gave their written informed consent
and the local ethics committee approved the study. Inclusion
criteria for each hemisphere were the presence of a beta peak
in the OFF levodopa condition and a minimum recording dur-
ation of 2min of artefact-free signal. Consequently, one subject
from the original study was not included.
Experiments and recordings
DBS electrodes were temporarily externalized prior to connec-
tion to the implantable pulse generator. LFP recordings were
Table 1 Clinical details
Subject Sex Age,
years
Disease
duration
Dominant symptoms Total UPDRS Stimulation
site
Beta peak
frequency
(Hz)
OFF/ON
levodopa (mg)
1 F 62 12 Bradykinesia, dyskinesia 37/16.5 L 25
(100 mg) R 24
2 M 69 18 Bradykinesia 52.5/29.5 L 29
(200 mg) R 17
3 F 48 8 Bradykinesia, dyskinesia, tremor 21.5/4 L 18
(200 mg) R 18
4 M 69 11 Bradykinesia, dyskinesia, freezing 24/18 L 14
(250 mg) R 16
5 M 57 17 Tremor 29.5/18 L 18
(200 mg) R 19
6 M 65 14 Tremor, motor fluctuation 38/28.5 L 25
(200 mg) R 25
7 F 63 5 Tremor 14.5/11 L 17
(200 mg) R 29
8 M 67 16 Tremor 46.5/25.5 L 12
(200 mg) R 12
Mean  SEM F(3): M(5) 62.5  2.5 12.6  1.6 33.0  4.6/18.9  3.1 19.9  2.0
(193.8  14.8)
F = female; L = left; M = male; OFF/ON levodopa represents the preoperative motor scores before and after the bracketed test dose of levodopa; R = right.
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performed with the patient quietly seated following overnight
withdrawal of antiparkinsonian medication before and after
administration of levodopa (test challenge dose in Table 1)
3–6 days after lead implantation. In four subjects (Subjects
1, 2, 6 and 8) LFPs were also recorded during self-paced, dis-
crete, front-and-back joystick movements; LFPs were recorded
from adjacent bipolar contact pairs (01, 12, 23) and the con-
tact pair with the highest beta power in the OFF condition was
selected for further analyses. Signals were ampliﬁed and ﬁl-
tered at 1–250Hz using a custom-made, high-impedance amp-
liﬁer (which had at its front end input stage the INA 128
instrumentation ampliﬁer, Texas Instruments) and recorded
through a 1401 analogue/digital converter (Cambridge
Electronic Design) onto a computer using Spike2 software
(Cambridge Electronic Design). Signals were sampled at
either 625Hz or 1 kHz. Before and after administration of
levodopa, motor symptoms were assessed using the Uniﬁed
Parkinson’s Disease Rating Scale (UPDRS). Half points were
used to increase the sensitivity of the test.
Signal processing and determination
of bursts
Figure 1 and Supplementary Fig. 1 illustrate the processing
steps involved in the discrimination of bursts of beta activity.
After visual signal inspection and artefact removal using
Spike2 Software, the data were imported into Matlab (version
R 2015b; MathWorks, Natick, MA), where all further signal
processing steps took place. Signal duration ranged from 136 s
to 365 s with a mean signal duration of 232.0  14.2 s for the
OFF condition and 231.9  15.5 s for the ON condition with-
out signiﬁcant difference [t(15) = 0.006, P = 0.995]. Signal dur-
ations between left and right STNs were matched in both OFF
and ON conditions.
The signal was resampled at 300Hz, highpass ﬁltered at
1Hz and decomposed using Wavelet transformation (ft_spe-
cest_wavelet script in Fieldtrip - Morlet Wavelet, width = 10,
gwidth = 5; Donders Institute for Brain, Cognition and
Behaviour, 2010) into frequency components between 1 and
40 Hz with the frequency resolution of 1 Hz. The beta peak
frequency (single frequency bin of 1 Hz) was selected in the
OFF levodopa state and the corresponding time evolved wave-
let amplitude was smoothed (0.2 s) and DC corrected (20 s
time constant) to adjust for potential baseline shifts in ampli-
tude, such as those due to variable ampliﬁer noise ﬂoor, and to
focus on the variance in beta amplitude. The determination of
bursts followed the same algorithm used and justiﬁed in our
previous study (Tinkhauser et al., 2017) and is summarized
below.
The duration of beta bursts was determined by the time
points at which the selected time evolved wavelet amplitude
exceeded a given amplitude threshold. Thresholds were deﬁned
in terms of percentiles of the DC corrected signal amplitude
distribution. However, as the precise amplitudes of percentile-
deﬁned thresholds could vary between ON and OFF
conditions, the applied threshold was set as the average of
the amplitudes corresponding to the selected percentile, and
the same threshold applied to both the conditions for a
given hemisphere. Thus when the text refers to, for example,
thresholding according to the 75th percentile, the same
threshold equivalent to the mean of the 75th percentiles
across conditions, was applied to each condition, unless other-
wise stated.
The selection of a given percentile amplitude threshold to
determine bursts is somewhat arbitrary, although previous
work has shown that relative differences in burst properties
during different conditions (no stimulation, adaptive DBS
and conventional DBS) were preserved across various ampli-
tude thresholds. To investigate if the same is true for beta
bursts OFF and ON levodopa, we additionally deﬁned them
using a range of different percentile thresholds (55, 60, 65, 70,
75, 80, 85, 90 percentiles) and include these data in our
results.
In general, we did not consider bursts with durations
shorter than 100ms (less that about two cycles in duration)
to limit the contribution of spontaneous ﬂuctuations in amp-
litude due to noise. The distribution of burst durations was
considered by categorizing them into nine time windows of
100ms starting from 100ms to 4900ms in duration (Fig. 1).
However, for illustrative purposes we have also included
bursts with very short durations between 0.05 s and 0.1 s as
a separate time window in Supplementary Fig. 2. Note that
the last time window (4900ms) includes bursts with a
broader range of duration. This was necessary as longer
bursts became progressively less frequent and like this we
ensured sufﬁcient burst numbers in each window. Since the
total signal duration could vary between subjects, instead of
the absolute number of bursts per time window, the percent-
age distribution of bursts was chosen. Burst duration is also
illustrated as mean burst duration without prior categoriza-
tion into time windows.
As noted above, the smoothed and DC-removed time
evolved wavelet amplitude of the beta peak frequency served
as a basis to determine beta bursts. However, to exclude the
possibility that shifts in the beta peak frequency over time or
between OFF and ON conditions affected the burst distribu-
tion, we repeated key analyses with a more relaxed beta peak
deﬁnition (beta peak  5Hz). Furthermore, to illustrate an
amplitude independent estimate of the burst dynamics we cal-
culated a wavelet-based frequency distribution (0.2 Hz to 2Hz
with frequency resolution of 0.1 Hz) of the time evolved beta
amplitude (same as used for burst segmentation) for both the
conditions.
For the recordings with self-paced joystick movements, de-
termination of beta bursts was performed as described previ-
ously, with a common 75th percentile amplitude threshold.
The total events per hemisphere were quantiﬁed and burst
characteristics, including burst duration and burst probability
(bursts/s), where derived from the 3 s before movement onset
and 1 s after movement onset (during movement).
Data analysis and statistics
The burst results were derived and compared at the level of
each hemisphere. To investigate the distribution of bursts with
different durations between the conditions, we performed a
two-way repeated measurement analysis of variance
(ANOVA) with a 9 2 design (nine time windows, two con-
ditions). Additionally, for each hemisphere the average burst
duration, the average burst amplitude, burst probability
(bursts/s), percentage time spent as burst as well as the burst
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probability and burst duration before and during movement
were calculated and compared.
The relationship between burst duration and burst amplitude
was calculated by applying a Spearman bivariate correlation
on all detected bursts (rs = Spearman’s rho) for each hemi-
sphere and condition and values were Fisher transformed
before averaging. Slopes between the conditions were com-
pared using the non-standardized coefﬁcient of the ﬁrst order
ﬁt (change in amplitude per time unit).
To compare burst dynamics between hemispheres, we ﬁrst
calculated the percentage number of beta bursts in a given
interval that were overlapping between the left and right hemi-
sphere for both the conditions at the frequency of the beta
peak. Since the beta peak frequency between the left and
right hemisphere can vary (Table 1), the percentage overlap-
ping was calculated for both hemispheric beta peak frequencies
and then averaged. The same algorithm was then repeated for
the 10 neighbouring frequency bins on the left and right of the
peak beta frequency. The coupling between bursts was inves-
tigated using the phase synchrony index (PSI) and compared
between related-overlapping (naturally co-occurring) bursts
and unrelated-overlapping, shufﬂed burst periods. Since the
duration of overlapping bursts varied, we only considered
the central overlapping 200ms of every burst. The activities
on the two sides during this period of bursting were independ-
ently concatenated to give two time series, either in correct
order or in a bilaterally independently shufﬂed order. The
PSI was then calculated. Accordingly, overlapping bursts
with 5200ms duration overlap did not contribute to PSI es-
timates. Similar to the calculation of the percentage burst over-
lapping between STNs, the PSI was calculated for peak beta
frequencies in both hemispheres and then averaged, since the
Figure 1 Burst determination. (A) A segment of the filtered LFP signal (5–40 Hz) and the time evolving wavelet amplitude (from the same
segment) of the beta peak frequency (18 Hz) derived from the wavelet transformed signal, both for OFF (grey) and ON (blue) levodopa. The red
dashed horizontal line illustrates the common amplitude threshold, which corresponds to the mean of the 75th percentile amplitudes of OFF and
ON levodopa. Periods of the time evolving wavelet amplitude that cross this threshold for longer than 0.1 s were defined as beta bursts. (B) The
LFP amplitude spectra for OFF and ON levodopa, with a beta peak at 18 Hz in the OFF levodopa condition and reduction of beta amplitude in the
ON levodopa condition. (C) Amplitude and duration of all detected beta bursts for both the conditions taken from recordings of 258 s and 318 s
duration. Example Subject 3, right side. (D) The average LFP amplitude spectra across all hemispheres for OFF and ON levodopa, with the
reduction of beta amplitude during the ON levodopa condition. Values are represented as mean + SEM. LD = levodopa.
Beta burst dynamics BRAIN 2017: 140; 2968–2981 | 2971
Downloaded from https://academic.oup.com/brain/article-abstract/140/11/2968/4430808
by Universitaetsbibliothek Bern user
on 22 March 2018
beta peak frequency between the left and right hemisphere
could vary (Table 1). The PSI was calculated according to
following formula, in which n is the number of time points,
and ’STN-Le is the phase angle for the left STN and ’STN-Ri the
phase angle for the right hemisphere.
PSI ¼ n1
Xn
t¼1
eið’STNLe’STNRiÞ ð1Þ
Key results such as burst duration, burst amplitude, and
percentage burst overlapping were not only compared between
ON and OFF state, but also to results obtained by chance.
This was achieved by shufﬂing of the raw LFP signal (1000
permutations) and thereafter by applying the same burst deter-
mination algorithm.
For the clinical correlations, we ﬁrst used the percentage
number of beta bursts in a given interval for each binned
burst duration and correlated them with clinical impairment,
to determine the overall relationship between burst duration
and motor performance.
The motor performance was given by the sum of the hemi-
body UPDRS Part III items (items 20 to 26), and separately
also as the sum of key sub-items (bradykinesia, rigidity and
tremor), contralateral to the side of LFP recording and bursts
considered as the percentage of short bursts and long bursts
relative to all the bursts from 100ms to 4900ms.
For the relationship between the change of burst duration and
clinical improvement we correlated the ratio between burst dur-
ation OFF levodopa and ON levodopa for the peak frequency
and the neighbouring frequencies (10 Hz) with the clinical im-
provement. The latter was derived using the following formula:
100 hemibody scoreOFF-med hemibody scoreON-medð Þ=
hemibody scoreOFF-med
ð2Þ
Statistical analyses were performed using IBM SPSS Statistics
Version 23. All data are presented as means  standard error
of the mean (SEM), unless otherwise stated. The assumption of
a normal distribution was tested by visual inspection of the
QQ-plots. Pairwise comparisons of burst parameters were per-
formed with paired t-tests. An exception was the burst analysis
during movement, where because of the low sample size (eight
hemispheres) non-parametric statistics (Wilcoxon signed rank
test) were applied and z-scores, pairs of comparisons and posi-
tive and negative ranks reported. If for the repeated measures
ANOVAs Mauchly’s test indicated that the assumption of
sphericity was violated, Greenhouse-Geisser corrections were
applied. To evaluate statistical signiﬁcance between the condi-
tions for burst duration and percentage overlapping across a
selection of frequencies (beta peak frequency  10 Hz) we used
a cluster-based permutation procedure: P-values were derived
by randomly permuting the assignment of condition labels for
all hemispheres/subjects 1000 times. For each frequency point
the z-statistic of the actual mean difference was computed
based on the distribution of the 1000 differences resulting
from permutation. The resulting P-values were then corrected
for multiple comparisons using a cluster-based permutation
approach. Then suprathreshold clusters (pre-cluster threshold:
P50.05) were determined for each permutation, and the sum
of the z-statistics within these clusters was stored to form a
distribution of the largest suprathreshold-cluster values.
Finally, the 95th percentile of this distribution served as stat-
istical threshold for the map of the actual z-statistics (Maris
and Oostenveld, 2007). Clinical correlations were performed
using Spearman’s correlation. For the comparison between
clinical improvement and ratio in burst duration between
OFF and ON levodopa, an additional bootstrap method was
used to determine the 95th conﬁdence interval of the correl-
ation coefﬁcients for each frequency bin. To control for mul-
tiple comparisons we performed the false discovery rate (FDR)
correction procedure, which controls the expected proportion
of falsely rejected hypotheses (Benajmini and Hochberg, 1995).
Results
Relative burst duration distribution
differs during OFF and ON levodopa
Figure 2 illustrates the percentage distribution of burst dur-
ations across different burst time windows (bins) and con-
ditions for the 75th percentile amplitude threshold. A
repeated measures ANOVA showed a signiﬁcant main
effect for the interaction between condition and burst dur-
ation [F(df 2.333) = 12.932, P50.001]. The corresponding
post hoc comparison between OFF levodopa and ON levo-
dopa showed that the percentage number of shorter beta
bursts (0.1–0.2 s; 0.2–0.3 s) in a given interval was higher
during ON levodopa compared to OFF levodopa
[t(15) = 4.257 P = 0.002, t(15) = 2.38 P = 0.047]. In
contrast, the percentage number of longer bursts (0.5–
0.6 s; 0.7–0.8 s; 0.8–0.9 s; 40.9 s) was higher during OFF
levodopa compared to ON levodopa [t(15) = 14.39,
P = 0.002; t(15) = 4.93, P5 0.001; t(15) = 2.51, P = 0.043;
t(15) = 3.96, P = 0.002]. The lack of signiﬁcant difference
between OFF and ON levodopa for the time windows 0.3–
0.5 is because of the averaging across hemispheres.
Individual hemispheres show a transition effect (from
short bursts being relatively preferred ON drug to long
bursts being relatively preferred OFF drug) over 0.3–0.5 s,
but as the precise transition point varies a little between
hemispheres there is no signiﬁcant change in these bins.
Supplementary Fig. 2 illustrates the relative burst distribu-
tion including bursts with duration shorter than 0.1 s (bin
range 0.05–0.1 s). These very short bursts show a similar
pattern, being signiﬁcantly more common during ON levo-
dopa compared to OFF levodopa, although the total
number of these bursts is smaller compared to that in the
neighbouring bin (0.1–0.2 s).
Burst duration and amplitude is
reduced ON levodopa
How does the duration of bursts change between condi-
tions without prior categorization of burst durations into
burst time windows? Figure 3A illustrates the difference in
mean burst duration before (0.406 s  0.030) and after ad-
ministration of levodopa [0.274 s  0.080; t(15) = 3.91,
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P = 0.001]. The signiﬁcant relationship is also present when
considering the mean of the individual median burst dur-
ations [0.297 s  0.014 versus 0.234 s  0.008; t(15) =
3.62, P = 0.003]. The percentage time of the total signal
spent as bursts was equally distributed across hemispheres
and conditions and higher during OFF levodopa compared
to ON levodopa [27.0  0.5% versus 16.1  1.7%;
t(15) = 4.95, P50.001] (Supplementary Fig. 3). The per-
centage burst time varied between hemispheres according
to levodopa responsiveness. When considering the ampli-
tude of beta bursts (Fig. 3B) we observed higher amplitude
before administration of levodopa [0.176 arbitrary units
(au)  0.039] compared to after administration of levodopa
[0.122 au  0.023; t(15) = 2.856, P = 0.012].
Above we selected the 75th percentile threshold as our
representative threshold to determine beta bursts. However,
because of the arbitrary nature of threshold selection we
also tested if the relationship between beta bursts OFF and
ON levodopa is maintained using a range of different
thresholds (55th to 90th percentile; Supplementary Fig.
4). This conﬁrmed that mean burst duration decreased
with rising amplitude threshold, while mean burst ampli-
tude increased. Importantly, however, the difference be-
tween bursts OFF and ON levodopa was maintained
across different thresholds, so that shorter bursts with
lower amplitudes were systematically more common
during ON levodopa compared to OFF levodopa.
Furthermore, we also contrasted burst duration and burst
amplitude with the same burst parameters derived from a
permutation of the raw LFP data using the same burst de-
termination algorithm, but (as in corresponding Fig. 3)
without prior categorization of burst durations into burst
time windows (Supplementary Fig. 5). The results showed
that in the OFF levodopa state the burst duration and burst
amplitude were both higher compared to the parameters
derived from the permutated data. In the ON levodopa
state, burst duration of the shufﬂed data was similar to
that of the original data, while burst amplitude was greater
in the original dataset. These results suggest that, even ON
levodopa, beta activity was organized into bursts of bigger
amplitude than expected by chance given the nature of the
LFP signal.
Burst duration and burst amplitude
are strongly related in both OFF and
ON levodopa
So far we have considered the duration and mean ampli-
tude of beta bursts separately. But how are these related
and how does levodopa impact on any such relationship?
Figure 4 illustrates the relationship in the two conditions.
Spearman correlation showed for each hemisphere a strong
positive and highly signiﬁcant correlation (OFF levodopa:
mean Fisher-transformed r-value 1.15  0.0325, P50.001
for all hemispheres; ON levodopa: mean Fisher-trans-
formed r-value 1.06  0.0340, P5 0.001 for all hemi-
spheres). The gradient of these ﬁts showed no difference
between OFF and ON levodopa [t(15) = 0.703,
P = 0.493], so that the differential distribution of burst dur-
ations between OFF and ON conditions largely determined
the different mean burst amplitudes in the two states.
However, Fig. 4 does not allow us to infer the shape of
the beta bursts, only that the longer they lasted the higher
the amplitude of the beta activity averaged across the dur-
ation of the burst. To address this, we measured where the
peak of each burst fell as a percentage of the total burst
duration. Regardless of drug state, the peak occurred
Figure 2 Change in burst duration distribution. Distribution of burst durations averaged across 16 sides as a percentage of total number
of bursts on each side, during OFF levodopa and ON levodopa, where bursts are defined as periods of beta activity that exceed the 75th
percentile amplitude threshold with a minimum duration of 0.1 s. During ON levodopa the percentage amount of shorter bursts (0.1–0.2 s, 0.2–
0.3 s) is higher and the percentage amount of long bursts (0.5–0.6 s, 0.7–0.8 s, 0.8–0.9 s,40.9 s) is lower in comparison to the OFF levodopa state.
Values are represented as mean + SEM; *Pcorr5 0.05. LD = levodopa.
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around 50% into the evolution of the burst (OFF levodopa
50.0  0.3%, ON levodopa 49.2  0.3%), consistent with
a spindle shape to the bursts.
Bursts occur less frequently during
ON levodopa and during movement
To investigate how often beta bursts occur, we calculated
the burst frequency as bursts/s (Fig. 3C). We found that the
frequency of bursts was lower during the ON levodopa
(0.58  0.056) compared to the OFF levodopa state
[0.70  0.03; t(15) = 3.52, P = 0.003], across all burst dur-
ations above 0.1 s. Supplementary Fig. 6 shows the distribu-
tion of the burst frequency for each time window before and
after levodopa. This demonstrates that the reduction in burst
frequency (Fig. 3C) is mainly driven by less frequently occur-
ring long duration beta bursts during ON levodopa.
Importantly, this comparison only takes into account beta
bursts in both conditions, which have a sufﬁcient magnitude
to be detected by the common 75th percentile amplitude
threshold and does not consider smaller variations of the
time evolved wavelet amplitude. The probability of short
bursts ON levodopa exceeded that OFF levodopa when
lower common thresholds were used (Supplementary Fig. 7).
Four of the subjects (eight hemispheres) were also re-
corded while they made self-paced, discrete front-and-
back joystick movements, as well as whilst they were
seated quietly at rest. In this albeit small sample, beta
burst frequency and duration were signiﬁcantly attenuated
when movements were made OFF levodopa, bringing beta
burst characteristics more in line with those seen ON levo-
dopa (Supplementary Fig. 8).
Change in burst properties is
preserved if definition of beta
bursts is changed
As part of the signal processing to derive beta bursts we
selected the wavelet transformed time signal corresponding
to the beta peak frequency (1 Hz bin, see Table 1). This
raises the possibility that, rather than a genuine shift in
beta bursts from long to short duration during ON levo-
dopa, a shift in burst frequency may lead to an over or
underestimation of burst duration at the original peak fre-
quency. To mitigate against this possibility, we repeated the
signal processing using a much broader deﬁnition of the
beta peak (beta peak  5Hz) (Supplementary Fig. 9). The
difference in burst duration was preserved between OFF
(0.39 s  0.018) and ON (0.31 s  0.01) medication
[t(15) = 3.944, P = 0.001]. The same was true for burst
amplitude, which was higher during OFF compared to
ON [t(15) = 3.14, P = 0.007] drug. These data suggest
that changes in burst duration are not a consequence of a
shift in beta peak frequency.
Similarly, both burst duration and amplitude were
reduced during ON levodopa compared to OFF levodopa
when the individual 75th percentile amplitude threshold in
each state was used to derive beta bursts instead of the
common amplitude threshold averaged across drug states
(Supplementary Fig. 10). This suggests that key state differ-
ences were not simply the product of differently scaled sig-
nals, but rather of real changes in the relative distribution
of burst durations and amplitudes within the two drug
states. Moreover, the ﬁndings were also preserved if we
considered the variation of the entire time evolved wavelet
amplitude of the peak beta activity, without being restricted
Figure 3 Change in burst duration, burst amplitude and burst probability. (A) The mean burst duration, derived from the mean
duration in each STN (without prior categorization into burst time windows) during OFF and ON levodopa. During ON levodopa, mean burst
duration is significantly reduced in comparison to OFF levodopa. The same significant differences were seen when we compare the average of the
individual median burst durations across conditions [0.297 s  0.015 versus 0.234 s  0.008; t(15) = 3.62, P = 0.003]. (B) The mean burst amp-
litude during OFF and ON levodopa. There is a significant reduction in burst amplitude after administration of levodopa. (C) The probability of
bursts to occur (illustrated as burst/s) is reduced after administration of levodopa. Beta bursts were determined using the 75th percentile
amplitude threshold. Values are represented as mean + SEM; *P5 0.05, **P5 0.01. LD = levodopa.
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to periods above a certain threshold. Supplementary Fig. 11
illustrates the relative variability of the time-evolved wave-
let amplitude (that was also selected for burst determin-
ation) for both the conditions. The relative amount of
slower amplitude variation (51Hz) that corresponds to
longer burst durations is greater during the OFF levodopa
condition, while the faster amplitude variation (41Hz),
which corresponds to shorter burst durations, is relatively
greater during the ON levodopa condition.
Beta bursts are coupled between
hemispheres
Hitherto we have examined the properties of beta bursts
within one hemisphere. How are beta bursts related between
hemispheres? To investigate the inter-hemispheric relationship
between beta bursts, we ﬁrst calculated the percentage of
burst periods that overlapped between the left and right
STN (Fig. 5A). We considered the beta peak frequency and
the neighbouring 10 1-Hz bins above and below this. The
difference in the percentage overlapping was frequency-spe-
ciﬁc and greatest around the individual beta peak. Figure 5B
illustrates the interhemispheric burst overlapping on a 10 s
signal period for both OFF and ON levodopa. Bursts at
the beta peak frequency overlapped OFF levodopa by
40.93  4.71%, and ON levodopa by 24.98  2.82% (Fig.
5C). Furthermore, for both the conditions beta bursts were
greater in their overlap than might be expected by chance
[t(15) = 4.71, P = 0.002; t(15) = 2.64 P = 0.03] (Fig. 5C).
Importantly, even though the duration of beta bursts was
similar between real data and shufﬂed data ON medication,
there was more overlapping of beta bursts between the two
hemispheres in the original data than the shufﬂed data. This
indicates that the increased overlapping could not just be due
to longer bursts in the two hemispheres. Next, we calculated
the PSI for related-overlapping bursts and shufﬂed unrelated-
overlapping bursts. We found a signiﬁcantly stronger PSI for
related compared to unrelated beta bursts for both OFF
[t(15) = 3.60, P = 0.009] and ON levodopa [t(15) = 2.69,
P = 0.0313] (Fig. 5D). However, there was no signiﬁcant dif-
ference in PSI between bursts OFF and ON levodopa if cu-
mulative burst durations were matched and compared
between conditions [t(15) = 0.9011, P = 0.398]. These results
suggest that the phase difference between the two hemi-
spheres in the beta band was consistent across all bursting
periods for both OFF and ON levodopa.
Clinical correlation
Finally, to investigate how burst duration in the OFF levo-
dopa state was related to clinical impairment, we correlated
the percentage number of beta bursts in a given interval
within different burst duration time windows with clinical
impairment (Fig. 6A), repeating this across different thresh-
olds (Fig. 6B). This showed that the percentage number of
beta bursts of longer duration was positively correlated
with clinical impairment, while the opposite was true for
bursts of shorter duration. When considering the UPDRS
sub-items (bradykinesia, rigidity and tremor) we found a
similar relationship, which however was weaker for the
tremor sub-item (Supplementary Fig. 12).
We also investigated how the relative change in burst
duration impacted on the clinical performance after admin-
istration of levodopa. Figure 6C illustrates the median burst
duration for both the conditions over a range of frequen-
cies (beta peak  10 Hz). Differences were signiﬁcant
Figure 4 Relationship between burst duration and burst amplitude. (A and B) The relationship between burst duration (x-axis,
depicted up to 3 s) and burst amplitude (y-axis) for all detected bursts across hemispheres. The dashed lines in grey show the first order fit
between the two variables for each hemisphere in each condition. The dashed line in red shows the mean first order fits across all hemispheres.
Each hemisphere shows a highly significant and positive correlation between burst duration and burst amplitude for both the conditions with a
mean r-value of 0.814  0.010 for OFF levodopa and 0.781  0.013 for ON levodopa. The r-values do not differ between conditions
[t(15) = 0.703, P = 0.493]. (C) Compares the slopes of the first order fits between OFF and ON levodopa, which are not significantly different
from each other. Beta bursts were determined using the 75th percentile amplitude threshold. Values are represented as mean + SEM.
LD = levodopa.
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around the individual beta peak (cluster-based permutation
test). The ratio between burst duration OFF and ON levo-
dopa was then correlated with the clinical improvement
after levodopa administration (Fig. 6D). Spearman’s rho
between decrease in burst duration and clinical improve-
ment was highest around the individual beta peak fre-
quency. Again, similar trends were observed when
UPDRS sub-items (bradykinesia, rigidity and tremor) were
considered individually (Supplementary Fig. 13). The 95th
conﬁdence interval around the beta peak was above the
mean r-value across frequency bins and the beta peak
area (Fig. 6C, peak 3Hz) was signiﬁcantly different
from the non-peak area [t(15) = 4.0884, P5 0.001]. In
summary, the change in the relative distribution of burst
durations between ON and OFF medication was linked to
the change in clinical state. Supplementary Fig. 6 suggests
that precisely what drove this change in distribution de-
pended on the common amplitude threshold used: with
higher amplitude thresholds the reduction in long duration
bursts by levodopa dominated, whereas with lower ampli-
tude thresholds there was an additional shift in favour of
more short duration bursts ON levodopa (Supplementary
Fig. 7).
Discussion
Our ﬁndings demonstrate that levodopa treatment changes
the relative distribution of beta bursts in the subthalamic
nucleus from long to short duration in patients with
Figure 5 Burst coupling between hemispheres. (A) The percentage of the total number of bursts that overlap in time between hemi-
spheres for the peak frequency of beta (averaged across the two sides) and surrounding frequencies. Data were realigned to the frequency of the
beta peak in each STN and then averaged. During OFF levodopa the percentage burst overlapping is significantly higher compared to ON
levodopa and also frequency-specific around the beta peak (cluster-based permutation test significance shown by orange bar). (B) Illustrates 10 s
of simultaneous time evolving wavelet amplitude for the beta peak frequency for the left and right hemisphere and both OFF (grey) and ON (blue)
levodopa. This illustrates the stronger burst overlapping (shaded areas) during OFF levodopa compared to ON levodopa (Subject 7).
(C) Contrasts the difference in percentage overlapping between the conditions for the beta peak frequency, with the overlapping by chance
(shuf = shuffled data). Both the conditions show a stronger overlapping compared to that expected by chance, with no difference in the over-
lapping by chance between the conditions. (D) The PSI between hemispheres for related-overlapping and shuffled unrelated-overlapping burst
(B = bursts) periods OFF and ON levodopa. The PSI for related bursts is much higher compared to unrelated bursts for both the conditions. Beta
bursts were determined using the 75th percentile amplitude threshold. Values are represented as mean + SEM; *P5 0.05.
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Parkinson’s disease withdrawn from drug treatment, so
that there are more long duration bursts OFF compared
to ON levodopa. The importance of this is that beta
burst amplitude progressively increases with burst duration.
The increase in burst amplitude as bursts last longer is in-
dicative of increasing local synchronization within the beta
band, and elsewhere we have speculated that excessive syn-
chronization at the local and circuit level can compromise
information coding capacity and thereby motor processing
(Brittain and Brown, 2014). In line with the presence of
more distributed synchronization, we found that beta
bursts are much more likely to occur simultaneously and
to be phase coupled across hemispheres than by chance in
Parkinson’s disease patients. Clinical correlations are con-
sistent with a deleterious effect of hypersynchronization in
long duration beta bursts. The percentage number of longer
beta bursts in a given interval OFF levodopa is positively
correlated with clinical impairment (with the opposite true
for the percentage number of shorter beta bursts).
Importantly, the decrease in burst duration after adminis-
tration of levodopa is also correlated with improvement in
motor deﬁcit.
In redistributing beta bursts in favour of those of shorter
duration and smaller amplitude, levodopa therefore has
similar effects to adaptive DBS. The same study showed
that the percentage number of short and long bursts differ-
entially correlate with motor impairment (Tinkhauser et al.,
2017). The parallels between the effects of dopaminergic
therapy and those of adaptive DBS help motivate the
development of the latter and to focus attention on the
dynamics of beta bursts as a rational target for closed-
loop DBS.
The likelihood and duration of beta
bursts
The levodopa-driven change in the relative distribution of
longer and shorter beta bursts was striking, could be
Figure 6 Clinical correlation. (A) Fisher transformed Spearman’s correlations between clinical impairment (total UPDRS items 20–26) and
the percentage amount of bursts during bursts of different durations for the OFF levodopa condition and 75th percentile amplitude threshold.
These show that a higher amount of shorter bursts tend to be negatively correlated with clinical impairment and a higher amount of longer bursts
tend to be positively correlated with clinical impairment. (B) Shows the same analysis as in A with Fisher transformed r-values averaged across
various percentile amplitude thresholds (55–90 percentile). The pattern of shorter bursts being negatively correlated with clinical impairment and
longer bursts being positively correlated, is not specific for the 75th percentile thresholds, but consistent across different thresholds. (C)
Illustrates the average of the median burst durations for OFF and ON levodopa, for the peak frequency of beta and 10 neighbouring frequencies
across sides. The significant changes in burst duration are frequency-specific and located around the beta peak frequency (cluster-based per-
mutation test significance shown by orange bar). (D) The r-values of the correlation between the ratio of median burst duration between the
conditions and the motor improvement in contralateral hemibody UPDRS at the beta peak frequency  10 Hz frequency bins. The positive
correlation is highest at the individual beta peak frequency. The horizontal line illustrates the mean r-value, the red dashed lines show the 95
confidence limits of the r-value density distribution of 10 000 bootstrap cycles (bootstrap method). Values are represented as mean  SEM (bars
and shaded areas). The relationships for burst duration and UPDRS sub-items are illustrated in Supplementary Fig. 12 and 13.
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replicated using a selection of different burst amplitude
thresholds, and was also evident in the spectral domain.
The latter conﬁrmed a relative shift in favour of amplitude
variability of higher frequency following levodopa admin-
istration indicative of a relative reduction in burst duration,
despite this being derived with an amplitude independent
method and thus not limited to suprathreshold signal per-
iods. Importantly, we were not just thresholding signals
with different standard deviations (differences in means
were removed by DC correction in our signal processing
pipeline) between drug states. Those bursts deﬁned by our
standard, common 75% amplitude threshold were longer
in the OFF levodopa state and bigger in amplitude in both
drug states than expected by chance. Other evidence that
bursts were not the product of simply thresholding signal
variance was their rich overlapping across hemispheres and
the bilateral synchronization during these overlapping
bursts. Moreover, differences in burst duration and ampli-
tude between drug states were preserved when we used
condition-speciﬁc amplitude thresholds. Finally, the
similarity of the results when using a broad as opposed
to a narrow beta frequency bandwidth militated against
a potential shift in beta peak frequency as an explan-
ation for the change in burst duration (Tinkhauser et al.,
2017).
The shift in the relative distribution of beta bursts to-
wards shorter durations following treatment with the
dopamine prodrug levodopa raises the possibility that
such bursts are more in keeping with the physiological
state. Such a conclusion is supported by studies con-
ducted in healthy non-human primates, which describe
beta bursts in the motor network as rather short events,
lasting for a few cycles only (Murthy and Fetz, 1992,
1996; Feingold et al., 2015). Also consistent with the
hypothesis that fewer and shorter bursts my be closer to
the physiological state is the fact that successful joystick
movements made OFF levodopa were accompanied by a
temporary reduction in the frequency and duration of
beta bursts.
In addition, beta bursts tended to be not only of
shorter duration and smaller amplitude on levodopa
but were also reduced in their probability, at least
when using a reasonably conservative amplitude thresh-
old. Previous work conducted in healthy non-human pri-
mates suggests that the diminution of burst probability
may underpin movement-related beta de-synchronization
in the striatum (Feingold et al., 2015), and highlights
burst likelihood as being another functionally relevant
parameter. Together, reduced burst duration and hence
amplitude, and reduced burst probability following
treatment with levodopa will contribute to the widely
reported suppression of mean beta levels in the ON
drug state (for review see Hammond et al., 2007). It
remains to be seen, however, whether these differences
are sufﬁcient to explain all of the suppression in mean
beta levels.
Relationship between burst duration
and synchronization
Why might the duration of beta bursts matter? For beta
activity to be recorded in the LFP neuronal activity has to
be synchronized so that spatiotemporal summation occurs.
In the STN such synchronization is likely to be mainly due
to afferent, synaptic activity (Weinberger and Dostrovsky,
2011). As the duration of beta bursts increases so does the
amplitude, indicative of progressive synchronization of
inputs over time. A similar relationship between burst dur-
ation and degree of synchronization has also been reported
in striatal recordings of non-human primates suggesting it
might be a general phenomenon of circuit dynamics where
some degree of lateral connectivity is present at the input
level or through intrinsic connectivity (Feingold et al., 2015).
Indeed, the phenomenon of increasing synchronization over
time as well as the coupling of co-occurring beta bursts be-
tween hemispheres may be an emergent property of neurons
acting as weakly coupled oscillators through network reson-
ance (Hahn et al., 2014). These effects in patients were pre-
sent for beta bursts both OFF and ON levodopa without
difference in the gradient relating duration to amplitude,
shape of bursts or in interhemispheric PSI, leading us to
posit that the difference between the OFF and ON drug
states may partly lie in the timing of the termination of
synchronization, i.e. of burst duration (Park et al., 2010;
Cagnan et al., 2015). Thus, a similar therapeutic effect can
be achieved by artiﬁcially limiting burst duration with adap-
tive DBS (Tinkhauser et al., 2017). Signiﬁcantly, this last
observation also provides evidence that the correlation be-
tween long duration bursts and motor impairment may arise
because long duration, higher amplitude beta bursts are
causally important in determining motor impairment.
Strikingly, it was not just local synchronization that was
evident in beta bursts. Periods of high amplitude beta sub-
stantially overlapped across hemispheres; less so ON than
OFF levodopa but still more than expected by chance.
Moreover, the phase synchrony during cotemporaneous bi-
lateral bursts was greater than between shufﬂed-not related
beta bursts in the same subject, but was not different be-
tween drug states. Previous studies have shown that beta
activity is coherent between STNs (de Solages et al., 2010)
and that this coherence is disrupted after administration of
levodopa (Little et al., 2013b), but they have not con-
sidered the dynamic nature of synchronization. Our ﬁnd-
ings suggest that the disruption of coherence between STN
activities by levodopa may be predominantly caused by a
reduction in burst probability and abbreviation of synchro-
nized bursts in the two hemispheres.
Study limitations
Importantly, recordings and clinical testing took place in
the immediate postoperative phase and a confounding
stun effect cannot be excluded (Chen et al., 2006). The
effect of levodopa on beta bursts should therefore be
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conﬁrmed in chronically implanted patients. We have also
distinguished between physiological, short duration, low
amplitude beta bursts and pathological, longer duration,
higher amplitude bursts, whereas it is likely that the
evolution from physiological to pathological Parkinson’s
disease-related beta bursts is a continuum, without a clear
demarcation that allows for a dichotomized categorization
of beta bursts. Rather, it may be the relative distribution of
bursts in terms of duration and amplitude that better serves
to characterize the normal and disease state, and we should
acknowledge here the possibility that the precise burst dis-
tribution characterizing the physiological state may not be
ﬁxed but vary according to context and task. In this regard,
it is important to note that we found that the probability
and duration of beta bursts were diminished during move-
ment, at least when OFF levodopa. Finally, in our analysis
we focused on the dynamics of beta activity, and it remains
possible that background tonic levels of beta activity are
also relevant in determining clinical state.
Implications for adaptive DBS
The transition from negative to positive correlation be-
tween burst duration and motor impairment occurred
with burst durations of 400–500ms, assuming a thresh-
old burst amplitude of 75%. This provides a benchmark
for adaptive DBS, which therefore would be best delivered
so as to trim bursts of longer duration than this and,
equally, to leave unaffected those that are shorter than
this. Through good fortune, rather than design, the adap-
tive DBS regimes that have been shown to be as, or more,
effective as conventional continuous DBS in patients OFF
medication have only been able to kick-in when burst dur-
ations exceeded a similar critical duration (Little et al.,
2013a, 2016a, b; Pina-Fuentes et al., 2017). Our ﬁndings
raise the possibility that adaptive systems that aim to
shorten the duration of beta bursts with a bang-bang (on/
off regulation) control algorithm may be preferable to those
involving a more gradual proportional–integral–derivative
control policy with substantial signal smoothing.
Depending on the degree of smoothing involved, the
latter may miss burst events or affect short duration
bursts. Nevertheless, further studies are required to deter-
mine the most efﬁcacious closed loop control algorithm and
then to compare the clinical performance of the adaptive
DBS system with the optimized control algorithm with that
provided by established conventional DBS.
Figure 7 Summary schematic. Illustrates the left and right STN with a series of beta bursts during OFF and ON levodopa located in the
dorso-lateral motor region (Horn et al., 2017). During OFF levodopa there are short and long duration beta bursts, while during ON levodopa
shorter bursts are predominant. Long duration beta bursts lead to a stronger phasic synchronization within the STN motor region, which is
related to motor impairment in Parkinson’s disease. Beta bursts co-occur between hemispheres and are phase coupled, while these overlapping
periods are more common during OFF levodopa compared to during ON levodopa.
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Our results also raise the possibility that stimulation may
need to be triggered even less often in the case of combined
levodopa treatment and adaptive DBS. This is because of
the reduction in burst probability and duration after ad-
ministration of levodopa. In the case of STN DBS this
could automatically prevent dyskinesia by reducing the
sum effect of stimulation and medication. Indeed in a pre-
vious adaptive DBS clinical trial it was seen that with
increasing levodopa effect, stimulation was triggered less
often (Little et al., 2016a) and other trials have shown
that dyskinesia are suppressed during adaptive DBS com-
pared to conventional DBS (Rosa et al., 2015, 2017).
Conclusion
Here we provide evidence that pathological beta activity
consists of prolonged bursts in Parkinson’s disease, that
these bursts are associated with excessive synchronization
within bilateral basal ganglia circuits and that longer dur-
ation bursts are abbreviated and made less frequent by
treatment with the dopaminergic prodrug, levodopa
(Fig. 7). Increases in the relative numbers of longer beta
bursts are correlated with clinical impairment, whereas the
reduction in burst duration correlates with improvement in
motor deﬁcit. These observations provide correlative evi-
dence that the distribution of burst durations distinguishes
the parkinsonian (OFF) and more physiological (ON) state
and may help determine motor function or deﬁcit. Adaptive
DBS may mimic the effect of levodopa in biasing burst dy-
namics in favour of relatively shorter, smaller bursts.
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